Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like Creative Bioarray Release: New Products of FISH Have Been Released In Company January 19, 2017 Patient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials July 5, 2017 New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures January 2, 2018
